{"title":"Semaglutide for weight management in adults","authors":"S. Chaplin","doi":"10.1002/psb.2066","DOIUrl":null,"url":null,"abstract":"Semaglutide (Wegovy) is a GLP‐1 analogue indicated as an adjunct to diet and physical activity for weight management in adults who are overweight or obese. This article discusses its efficacy, adverse effects and place in therapy.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Semaglutide (Wegovy) is a GLP‐1 analogue indicated as an adjunct to diet and physical activity for weight management in adults who are overweight or obese. This article discusses its efficacy, adverse effects and place in therapy.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
